Roche has returned the rights to UCB’s anti-tau antibody bepranemab, walking away from a $120 million bet on the Alzheimer’s ...
UCB today announced that the company has regained all global rights to bepranemab following termination of a collaboration ...
United Community Banks, Inc. (NYSE:UCB) Q3 2024 Earnings Call Transcript October 23, 2024 Operator: Good morning and welcome to United Community Bank's Third Quarter 2024 Earnings Call. Hosting the ...
Roche drops a third Alzheimer’s candidate this year, terminating a partnership with UCB just four years after agreeing to ...
Yale spinout Modifi agreed to sell to Merck for $30 million upfront. Elsewhere, Sangamo plotted a much faster path to market ...
UCB recently hosted the orientation programme for this year’s third intake of the Monash College Diploma programme.
October 17, 2024, 13:48 pm ET, BY Jolene W.- Contributor| Editor: Thomas H. Kee Jr. ( Follow on LinkedIn) Short UCB slightly ...